Annual Non Current Assets
$20.99 M
-$12.51 M-37.33%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual long term assets is currently $20.99 million, with the most recent change of -$12.51 million (-37.33%) on 31 December 2023. During the last 3 years, it has fallen by -$1.02 million (-4.64%). BCRX annual non current assets is now -64.15% below its all-time high of $58.56 million, reached on 31 December 2015.BCRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$64.13 M
-$44.83 M-41.15%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly long term assets is currently $64.13 million, with the most recent change of -$44.83 million (-41.15%) on 30 September 2024. Over the past year, it has increased by +$43.13 million (+205.46%). BCRX quarterly non current assets is now -41.15% below its all-time high of $108.96 million, reached on 30 June 2024.BCRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +205.5% |
| 3 y3 years | -4.6% | +191.3% |
| 5 y5 years | +92.0% | +486.4% |
BCRX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.3% | at low | -41.1% | +308.9% |
| 5 y | 5 years | -37.3% | +92.3% | -41.1% | +501.6% |
| alltime | all time | -64.2% | +1399.6% | -41.1% | +5244.1% |
BioCryst Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $64.13 M(-41.1%) |
| June 2024 | - | $108.96 M(+424.1%) |
| Mar 2024 | - | $20.79 M(-1.0%) |
| Dec 2023 | $447.74 M(-13.3%) | $20.99 M(+2.6%) |
| Sept 2023 | - | $20.46 M(+8.7%) |
| June 2023 | - | $18.83 M(-0.1%) |
| Mar 2023 | - | $18.85 M(-43.7%) |
| Dec 2022 | $516.50 M(-8.8%) | $33.50 M(-32.5%) |
| Sept 2022 | - | $49.59 M(+216.2%) |
| June 2022 | - | $15.69 M(-2.0%) |
| Mar 2022 | - | $16.01 M(-27.3%) |
| Dec 2021 | $566.14 M(+74.8%) | $22.02 M(+69.1%) |
| Sept 2021 | - | $13.02 M(+13.4%) |
| June 2021 | - | $11.48 M(+7.7%) |
| Mar 2021 | - | $10.66 M(-2.3%) |
| Dec 2020 | $323.80 M(+97.0%) | $10.91 M(-20.8%) |
| Sept 2020 | - | $13.79 M(+26.9%) |
| June 2020 | - | $10.87 M(-1.9%) |
| Mar 2020 | - | $11.08 M(+1.3%) |
| Dec 2019 | $164.34 M(+43.7%) | $10.94 M(-6.5%) |
| Sept 2019 | - | $11.70 M(-7.4%) |
| June 2019 | - | $12.63 M(-48.9%) |
| Mar 2019 | - | $24.69 M(-24.0%) |
| Dec 2018 | $114.35 M(-8.8%) | $32.49 M(-18.4%) |
| Sept 2018 | - | $39.81 M(-9.5%) |
| June 2018 | - | $43.98 M(-14.1%) |
| Mar 2018 | - | $51.22 M(-3.1%) |
| Dec 2017 | $125.39 M(+87.2%) | $52.87 M(+227.9%) |
| Sept 2017 | - | $16.12 M(-24.1%) |
| June 2017 | - | $21.25 M(+32.7%) |
| Mar 2017 | - | $16.01 M(-30.0%) |
| Dec 2016 | $66.99 M(+5.0%) | $22.86 M(-14.9%) |
| Sept 2016 | - | $26.87 M(-25.6%) |
| June 2016 | - | $36.10 M(-31.2%) |
| Mar 2016 | - | $52.46 M(-10.4%) |
| Dec 2015 | $63.79 M(-28.6%) | $58.56 M(+7.5%) |
| Sept 2015 | - | $54.45 M(+26.4%) |
| June 2015 | - | $43.09 M(-11.2%) |
| Mar 2015 | - | $48.50 M(+2.0%) |
| Dec 2014 | $89.34 M(+112.1%) | $47.53 M(+2299.3%) |
| Sept 2014 | - | $1.98 M(-46.8%) |
| June 2014 | - | $3.73 M(-51.3%) |
| Mar 2014 | - | $7.66 M(+13.5%) |
| Dec 2013 | $42.12 M(+0.3%) | $6.75 M(+6.0%) |
| Sept 2013 | - | $6.37 M(-0.3%) |
| June 2013 | - | $6.39 M(-44.4%) |
| Mar 2013 | - | $11.49 M(-25.7%) |
| Dec 2012 | $41.98 M(-20.6%) | $15.46 M(-11.7%) |
| Sept 2012 | - | $17.51 M(-43.8%) |
| June 2012 | - | $31.17 M(+14.9%) |
| Mar 2012 | - | $27.14 M(-7.5%) |
| Dec 2011 | $52.86 M(-39.5%) | $29.35 M(-8.5%) |
| Sept 2011 | - | $32.06 M(+12.4%) |
| June 2011 | - | $28.54 M(+27.9%) |
| Mar 2011 | - | $22.32 M(+1.3%) |
| Dec 2010 | $87.42 M(-21.3%) | $22.03 M(+2.0%) |
| Sept 2010 | - | $21.59 M(-40.6%) |
| June 2010 | - | $36.35 M(+14.1%) |
| Mar 2010 | - | $31.86 M(+2.2%) |
| Dec 2009 | $111.02 M | $31.17 M(+214.8%) |
| Sept 2009 | - | $9.90 M(+36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $7.24 M(-3.1%) |
| Mar 2009 | - | $7.47 M(-22.7%) |
| Dec 2008 | $75.02 M(-18.2%) | $9.67 M(-49.8%) |
| Sept 2008 | - | $19.24 M(-63.0%) |
| June 2008 | - | $52.03 M(+0.3%) |
| Mar 2008 | - | $51.88 M(+1.7%) |
| Dec 2007 | $91.70 M(+100.3%) | $51.01 M(+2.9%) |
| Sept 2007 | - | $49.59 M(+83.7%) |
| June 2007 | - | $27.00 M(+30.9%) |
| Mar 2007 | - | $20.63 M(-9.1%) |
| Dec 2006 | $45.79 M(-43.5%) | $22.70 M(-28.0%) |
| Sept 2006 | - | $31.54 M(+3.0%) |
| June 2006 | - | $30.63 M(+0.7%) |
| Mar 2006 | - | $30.43 M(+67.7%) |
| Dec 2005 | $81.10 M(+239.7%) | $18.15 M(+171.9%) |
| Sept 2005 | - | $6.67 M(-30.7%) |
| June 2005 | - | $9.63 M(+23.8%) |
| Mar 2005 | - | $7.78 M(-9.5%) |
| Dec 2004 | $23.87 M(+15.3%) | $8.60 M(-40.1%) |
| Sept 2004 | - | $14.36 M(-15.8%) |
| June 2004 | - | $17.06 M(+1.2%) |
| Mar 2004 | - | $16.86 M(+79.6%) |
| Dec 2003 | $20.70 M(-17.0%) | $9.39 M(-22.2%) |
| Sept 2003 | - | $12.06 M(+24.8%) |
| June 2003 | - | $9.66 M(-35.6%) |
| Mar 2003 | - | $15.01 M(-8.3%) |
| Dec 2002 | $24.93 M(-23.1%) | $16.37 M(+1.0%) |
| Sept 2002 | - | $16.21 M(-19.5%) |
| June 2002 | - | $20.15 M(-13.1%) |
| Mar 2002 | - | $23.20 M(-13.1%) |
| Dec 2001 | $32.40 M(+25.8%) | $26.69 M(-14.5%) |
| Sept 2001 | - | $31.22 M(-3.8%) |
| June 2001 | - | $32.44 M(-4.5%) |
| Mar 2001 | - | $33.98 M(-24.6%) |
| Dec 2000 | $25.76 M(+4.7%) | $45.07 M(-1.9%) |
| Sept 2000 | - | $45.92 M(-2.8%) |
| June 2000 | - | $47.23 M(-2.5%) |
| Mar 2000 | - | $48.43 M(-0.8%) |
| Dec 1999 | $24.60 M(+7.4%) | $48.80 M(+662.5%) |
| Sept 1999 | - | $6.40 M(-22.9%) |
| June 1999 | - | $8.30 M(+13.7%) |
| Mar 1999 | - | $7.30 M(+17.7%) |
| Dec 1998 | $22.90 M(+16.2%) | $6.20 M(+287.5%) |
| Sept 1998 | - | $1.60 M(-5.9%) |
| June 1998 | - | $1.70 M(-57.5%) |
| Mar 1998 | - | $4.00 M(-41.2%) |
| Dec 1997 | $19.70 M(-29.9%) | $6.80 M(+47.8%) |
| Sept 1997 | - | $4.60 M(+12.2%) |
| June 1997 | - | $4.10 M(-61.7%) |
| Mar 1997 | - | $10.70 M(+18.9%) |
| Dec 1996 | $28.10 M(+140.2%) | $9.00 M(+650.0%) |
| Sept 1996 | - | $1.20 M(-7.7%) |
| June 1996 | - | $1.30 M(0.0%) |
| Mar 1996 | - | $1.30 M(-7.1%) |
| Dec 1995 | $11.70 M(+5.4%) | $1.40 M(0.0%) |
| Sept 1995 | - | $1.40 M(-6.7%) |
| June 1995 | - | $1.50 M(-6.3%) |
| Mar 1995 | - | $1.60 M(-5.9%) |
| Dec 1994 | $11.10 M | $1.70 M(0.0%) |
| Sept 1994 | - | $1.70 M(-5.6%) |
| June 1994 | - | $1.80 M(-59.1%) |
| Mar 1994 | - | $4.40 M |
FAQ
- What is BioCryst Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly non current assets year-on-year change?
What is BioCryst Pharmaceuticals annual long term assets?
The current annual non current assets of BCRX is $20.99 M
What is the all time high annual non current assets for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual long term assets is $58.56 M
What is BioCryst Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of BCRX is $64.13 M
What is the all time high quarterly non current assets for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly long term assets is $108.96 M
What is BioCryst Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, BCRX quarterly long term assets has changed by +$43.13 M (+205.46%)